Sign inJoin waitlistJoin the waitlist

Robert Wesolowski

Physician · Ohio State University College of Medicine

Credentials: · · ·

History

Ohio State University College of Medicine
Present

Cleveland Clinic Foundation
2007–2009
Internal Medicine
2004–2007
Doctor of Medicine
2000–2004

Research

Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer
Review · Journal for ImmunoTherapy of Cancer · 2013 · Co-first of 3 authors · 242 citations
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function
Clinical Cancer Research · 2018 · 208 citations
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial
JAMA · 2022 · 199 citations

BR
Bhuvaneswari Ramaswamy
61 papers
Maryam Lustberg
61 papers
Daniel Stover
56 papers
Nicole Williams
54 papers
Sagar Sardesai
54 papers
Matthew Cherian
37 papers
Raquel Reinbolt
32 papers · 3 as a fellow
JV
Jeffrey VanDeusen
26 papers
Margaret Gatti-Mays
26 papers
Anne Noonan
24 papers
William Carson
23 papers
Dionisia Quiroga
22 papers

Grants

Training Hematology and Oncology Fellows in Clinical Research
National Cancer Institute · T32
PI · $518.1K · Ohio State University
2020–2026

Clinical trials

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors
Principal investigator · Completed · Phase 1
Ohio State University Comprehensive Cancer Center
2018–2022
Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast Cancer
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
2016–2022
Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Principal investigator · Completed · Phase 1
Robert Wesolowski
2011–2022
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2033